Research lags in business ventures

Research lags in business ventures

November 11, 2015

From The Australian:

Imagine if universities had to compete with each other to get research work from businesses armed with their own government research grants? Stephen Tomisich, head of Melbourne-based medical technology company Trajan Scientific and Medical...

Read the full article at The Australian website: Research lags in business ventures

Stephen Tomisich, Director and Chief Executive Officer, Trajan Scientific and Medical




Also in News

Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti

November 30, 2020

Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.

This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.

Read More

Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions

November 11, 2020

In celebration of International Pathology Day, Trajan Scientific and Medical (Trajan) is proud to announce a new partnership with ScyTek Laboratories (ScyTek) to deliver quality immunohistochemistry (IHC) solutions.

Read More

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More